The global sacral nerve stimulation market is witnessing significant growth due to increasing prevalence of overactive bladder and urge incontinence globally. According to the National Association for ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

After receiving an FDA approval earlier this week for its newly miniaturized and rechargeable sacral nerve stimulator, Medtronic reported that its first patient has received the implant through the ...

Please provide your email address to receive an email when new articles are posted on . According to a company release, the R20 neurostimulator has been labeled for a functional life span of at least ...

NEW HAVEN, Conn. (WTNH) — In your health update today: bowel incontinence affects more than 20 percent of adults but is often not talked about. Our guest today wants to open up communication on the ...

Certain healthcare conditions often go unspoken, leading to silent struggles that affect the lives of many. Overactive bladder (OAB) and fecal incontinence (FI) are two such conditions, impacting ...

Medtronic plc has won U.S. FDA approval of its Interstim Micro rechargeable sacral nerve stimulator and Interstim Surescan MRI leads for the treatment of urinary and bowel dysfunctions. The new ...

Potential advantages of peroneal nerve stimulation include its noninvasiveness and relatively mild side effects. Peroneal electrical transcutaneous nerve modulation appears safe and tolerable for ...

Current evidence on the safety and efficacy of sacral nerve stimulation for faecal incontinence appears adequate to support the use of this procedure, provided that the normal arrangements are in ...